Oral health status assessment for participants undergoing gender affirming hormone treatment
Recruiting
- Conditions
- one
- Registration Number
- NL-OMON23787
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Mentally competent
- Age between 18 and 35 years old
- Non-smokers
- For trans men: only individuals using Androgel at the start of the study
- Last visit to the dentist 1 year ago or less
Exclusion Criteria
- Evidence of any systemic disease or compromised health condition
- Medication use (on a daily basis, other than medication for the purpose of GAHT)
- Use of antibiotics during the last 2 months
- Use of antifungals during the last 2 months
- Need of antibiotic prophylaxis prior to dental treatment
- The use of anti-inflammatory drugs on a regular basis
- Long-term prescribed medication
- Active periodontal disease: pockets = 5mm and/or more than 50% of bleeding sites assessed by bleeding on probing (BOP)
- Overt caries
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary aim of this study is to determine the effects of GAHT on the oral health status of the participants undergoing GAHT therapy.
- Secondary Outcome Measures
Name Time Method Secondary objectives include the assessment of periodontal status, assessment of clinical changes by means of QLF technology, assessment of levels of hormones in saliva, assessment of the microbiological/mycobiological changes secondary to the hormonal therapy and assessment of the self-perception of the participants regarding their oral status.